{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:26:24Z","timestamp":1793996784648,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["20610"],"award-info":[{"award-number":["20610"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["ZSU3105"],"award-info":[{"award-number":["ZSU3105"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xphs.2025.104053","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:38:20Z","timestamp":1761982700000},"page":"104053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Formulation and in vitro evaluation of liposomal and self-microemulsifying drug delivery systems for oral delivery of cannabidiol"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-1236","authenticated-orcid":false,"given":"Chrystalla","family":"Protopapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6117-6250","authenticated-orcid":false,"given":"Ioannis","family":"Tsichlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6037-9721","authenticated-orcid":false,"given":"Siva Satyanarayana","family":"Kolipaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Douroumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-4314","authenticated-orcid":false,"given":"Costas","family":"Demetzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-705X","authenticated-orcid":false,"given":"Marilena","family":"Vlachou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2025.104053_bib0001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/pop.2018.0113","article-title":"Trends in publications on medical cannabis from the year 2000","volume":"22","author":"Treister-Goltzman","year":"2019","journal-title":"Popul Health Manag"},{"issue":"4","key":"10.1016\/j.xphs.2025.104053_bib0002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.xphs.2025.104053_bib0003","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.xphs.2025.104053_bib0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/cells9020307","article-title":"Cannabis Sativa revisited\u2014Crosstalk between microRNA expression, inflammation, oxidative stress, and endocannabinoid response system in critically ill patients with sepsis","volume":"9","author":"Dinu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.xphs.2025.104053_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Braz J Psychiatry"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.xphs.2025.104053_bib0007","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/ptr.6165","article-title":"Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: clinical and histological evaluation","volume":"32","author":"Klein","year":"2018","journal-title":"Phytother Res"},{"issue":"7","key":"10.1016\/j.xphs.2025.104053_bib0008","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Fut Med Chem"},{"key":"10.1016\/j.xphs.2025.104053_bib0009","unstructured":"FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD) | FDA. Accessed August 29, 2025. https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd."},{"issue":"3","key":"10.1016\/j.xphs.2025.104053_bib0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1208\/s12248-016-9898-x","article-title":"Use of the Biopharmaceutics drug disposition classification system (BDDCS) to help predict the occurrence of idiosyncratic cutaneous adverse drug reactions associated with antiepileptic drug usage","volume":"18","author":"Chan","year":"2016","journal-title":"AAPS J"},{"issue":"7","key":"10.1016\/j.xphs.2025.104053_bib0011","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drudis.2010.02.009","article-title":"Nanonization strategies for poorly water-soluble drugs","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0012","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2012.08.042","article-title":"Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs","volume":"453","author":"Lu","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2025.104053_bib0014","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2025.104053_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/phar.2377","article-title":"Model-based analysis of cannabidiol dose-exposure relationship and bioavailability","volume":"40","author":"Lim","year":"2020","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"issue":"8","key":"10.1016\/j.xphs.2025.104053_bib0016","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.xphs.2025.104053_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762738","article-title":"Reviewing the role of the endocannabinoid system in the pathophysiology of depression","volume":"12","author":"Gallego-Landin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"30","key":"10.1016\/j.xphs.2025.104053_bib0018","doi-asserted-by":"crossref","first-page":"E6034","DOI":"10.1073\/pnas.1610325114","article-title":"Anti-inflammatory \u03c9-3 endocannabinoid epoxides","volume":"114","author":"McDougle","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.xphs.2025.104053_bib0019","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.xphs.2017.12.020","article-title":"PTL401, a new formulation based on pro-nano dispersion technology, improves oral cannabinoids bioavailability in healthy volunteers","volume":"107","author":"Atsmon","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.104053_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.09.011","article-title":"Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration","volume":"266","author":"Cherniakov","year":"2017","journal-title":"J Control Rel"},{"issue":"6","key":"10.1016\/j.xphs.2025.104053_bib0021","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/10717544.2014.896058","article-title":"Self-microemulsifying drug delivery system (SMEDDS) \u2013 challenges and road ahead","volume":"22","author":"Dokania","year":"2015","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2025.104053_bib0022","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Neslihan Gursoy","year":"2004","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.xphs.2025.104053_bib0023","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/03639040500216428","article-title":"Preparation and evaluation of SEDDS and SMEDDS containing Carvedilol","volume":"31","author":"Wei","year":"2005","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2025.104053_bib0024","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2012.03.015","article-title":"Novel solid self-emulsifying drug delivery system of coenzyme Q10 with improved photochemical and pharmacokinetic behaviors","volume":"46","author":"Onoue","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-5173(02)00003-0","article-title":"Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation","volume":"235","author":"Nazzal","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104053_bib0026","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.2147\/IJN.S211014","article-title":"Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate","volume":"14","author":"Kim","year":"2019","journal-title":"Int J Nanomed"},{"issue":"5","key":"10.1016\/j.xphs.2025.104053_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.xphs.2025.104053_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0029","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-3659(98)00180-1","article-title":"Improvement of temperature-sensitivity of poly(N-isopropylacrylamide)-modified liposomes","volume":"59","author":"Kono","year":"1999","journal-title":"J Control Rel"},{"issue":"16","key":"10.1016\/j.xphs.2025.104053_bib0031","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.3390\/ma16165509","article-title":"Development of liposomal and liquid crystalline lipidic nanoparticles with non-ionic surfactants for quercetin incorporation","volume":"16","author":"Tsichlis","year":"2023","journal-title":"Materials"},{"issue":"12","key":"10.1016\/j.xphs.2025.104053_bib0032","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1039\/D3MH00717K","article-title":"Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results","volume":"10","author":"Filippov","year":"2023","journal-title":"Mater Horiz"},{"key":"10.1016\/j.xphs.2025.104053_bib0033","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.colsurfa.2015.08.044","article-title":"Standardization and validation of a protocol of zeta potential measurements by electrophoretic light scattering for nanomaterial characterization","volume":"486","author":"Varenne","year":"2015","journal-title":"Colloids Surf A: Physicochem Eng Asp"},{"issue":"70","key":"10.1016\/j.xphs.2025.104053_bib0034","article-title":"Synthesis of (-)-cannabidiol (CBD), (-)-\u03949- and (-)-\u03948-tetrahydrocannabinols, encapsulation of CBD with nanoparticles for controlled delivery and biological evaluation","volume":"30","author":"Moya-Utrera","year":"2024","journal-title":"Chemistry (Easton)"},{"issue":"6","key":"10.1016\/j.xphs.2025.104053_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/metabo12060480","article-title":"Direct In vivo analysis of CBD- and THC-acid cannabinoids and classification of cannabis cultivars using SpiderMass","volume":"12","author":"Ogrinc","year":"2022","journal-title":"Metabolites"},{"issue":"22","key":"10.1016\/j.xphs.2025.104053_bib0036","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3390\/ma17225454","article-title":"Impact of pluronic F-127 on the stability of quercetin-loaded liposomes: insights from DSC preformulation studies","volume":"17","author":"Kosti","year":"2024","journal-title":"Materials"},{"issue":"8","key":"10.1016\/j.xphs.2025.104053_bib0037","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/pharmaceutics15082073","article-title":"Formulation and evaluation of a self-microemulsifying drug delivery system of raloxifene with improved solubility and oral bioavailability","volume":"15","author":"Ansari","year":"2023","journal-title":"Pharmaceutics"},{"issue":"70","key":"10.1016\/j.xphs.2025.104053_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202402496","article-title":"Synthesis of (\u2212)-cannabidiol (CBD), (\u2212)-\u03949- and (\u2212)-\u03948-tetrahydrocannabinols, encapsulation of CBD with nanoparticles for controlled delivery and biological evaluation","volume":"30","author":"Moya-Utrera","year":"2024","journal-title":"Chem \u2013 A Eur J"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02859-2","article-title":"Exploring the interconnected properties of cannabidiol suspensions and orodispersible films","volume":"15","author":"Vlad","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xphs.2025.104053_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2025.104053_bib0041","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/pharmaceutics16030385","article-title":"In vitro profile of hydrocortisone release from three-dimensionally printed paediatric mini-tablets","volume":"16","author":"Protopapa","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2025.104053_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0023-6438(95)80008-5","article-title":"Use of a free radical method to evaluate antioxidant activity","volume":"28","author":"Brand-Williams","year":"1995","journal-title":"LWT - Food Sci Technol"},{"issue":"13","key":"10.1016\/j.xphs.2025.104053_bib0043","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jf020071c","article-title":"Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals","volume":"50","author":"Kim","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.xphs.2025.104053_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124594","article-title":"Sustained release of 3D printed bupropion hydrochloride tablets bearing Braille imprints for the visually impaired","volume":"663","author":"Protopapa","year":"2024","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:19:38Z","timestamp":1766582378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0022354925005076"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104053","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and in vitro evaluation of liposomal and self-microemulsifying drug delivery systems for oral delivery of cannabidiol","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"104053"}}